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This paper presents the multiresidue determination of the series of quinolones regulated by the 33 
European Union (marbofloxacin, ciprofloxacin, danofloxacin, enrofloxacin, sarafloxacin, 34 
difloxacin, oxolinic acid and flumequine) in bovine and porcine plasma using capillary 35 
electrophoresis and liquid chromatography with ultraviolet detection (CE-UV, LC–UV), liquid 36 
chromatography–mass spectrometry and –tandem mass spectrometry (LC–MS, LC-MS/MS) 37 
methods. These procedures involve a sample preparation by solid-phase extraction (SPE) for 38 
clean-up and preconcentration of the analytes before their injection in the separation system. All 39 
methods give satisfactory results in terms of linearity, precision, accuracy and limits of 40 
quantification. The suitability of the methods to determine quinolones was evaluated by 41 
determining the concentration of enrofloxacin and ciprofloxacin in real samples from pig plasma 42 
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1. INTRODUCTION 52 
Many classes of antibiotics are widely administered to food-producing animals such as cattle, 53 
swine and poultry for the purposes of prevention and treatment of several diseases as well as for 54 
promoting growth (Stolker et al. 2005). As a result, these substances can be present in food 55 
products of animal-origin and may pose a health threat to consumers (Blasco et al. 2007; 56 
Companyó et al. 2009). 57 
There is increasing international concern that the indiscriminate use of quinolones and other 58 
antibiotics has led to increased bacterial resistance. Resistant bacteria from animals can infect the 59 
human population not only by direct contact but also via food product of animal origin. These 60 
resistant bacteria can colonise humans or transfer their resistance genes to other bacteria 61 
belonging to the endogenous human flora (Fabrega et al. 2008). This is now regarded as a public 62 
health hazard, primarily due to the increasing prevalence of treatment failures (Turnidge 2004). 63 
The World Health Organisation, has recommended the discontinuing use of antimicrobial growth 64 
promoters that belong to an antimicrobial class used in humans. The Health Ministries in the 65 
European Union agreed to discontinue the use of all antimicrobial growth promoters by 2002 66 
(Angulo et al. 2004). To ensure safety, the European Union (EU) has established safe maximum 67 
residue limits (MRLs) for residues of veterinary drugs in those animal tissues that enter the 68 
human food chain (Council Regulation (EEC) No. 2377/90) (Comission EU 1990). It is hoped 69 
that this will minimize the risks to human health. The development of accurate and sensitive 70 
methods in biological fluids as plasma or serum could be of great interest to relate its content 71 
with the amount of quinolone in tissue without requiring the immediate slaughter of the animal.  72 
There are numerous studies and reviews in the literature addressing quinolones determination in 73 
the veterinary field (Blasco et al. 2007; Companyó et al. 2009; Moreno-Bondi et al. 2009; 74 
Boglialli et al. 2007; Garcés et al. 2006; Van Hoof et al. 2005; Pecorelli et al. 2005; Hermo et al.75 
2005; Hermo et al. 2006; Bailac et al. 2004). There are a great number of studies specifically 76 
addressing to determination of quinolones in animal tissues. Most papers focus on a specific 77 
matrix such as muscle, kidney or liver, but the number of studies specifically addressing 78 
quinolones in bovine or pig plasma remains quite low and generally analysing only two or three 79 
quinolones (Hernández-Arteseros et al. 2002; Idowu et al. 2004). 80 
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 Most of the methodologies currently applied to quinolone sample preparation in either plasma or 81 
serum are based on solid-phase extraction (SPE) techniques due to its inherent double function: 82 
pre concentration and clean-up of extracts (Samanidou et al. 2005; Zoutendam et al. 2003). 83 
In the recent decade, separation techniques, primarily liquid chromatography (LC) and capillary 84 
electrophoresis (CE) coupled to ultraviolet detection (UV), fluorescence detection (FD), and mass 85 
spectrometry (MS) have been widely used for drugs analyses involving complex samples (Hermo 86 
et al. 2005; Hermo et al. 2006; Hernández-Arteseros et al. 2002; Jiménez-Lozano et al. 2004). 87 
The use of electrospray ionization (ESI) sources and tandem MS (MS/MS) instruments has 88 
allowed for improvements in sensitivity as well as in reduced analysis time, making it possible to 89 
rapidly achieve complete analyte separation (Picó et al. 2008; Le Bizec et al. 2009; Bogialli et al.90 
2009; Andreu et al. 2007; Hermo et al. 2008). 91 
The present paper describes the optimization and validation of a new method allowing for the 92 
simultaneous identification and quantification of eight quinolones by CE-UV, LC-UV, LC-MS, 93 
and LC-MS/MS in plasma samples. Several solid-phase extraction (SPE) cartridges were tested 94 
for the clean-up purposes in order to obtain cleaner extracts and better recoveries. Quality control 95 
parameters (Commission EU 2002; US Department 2001) were established and compared when 96 
the samples of cow and pig plasma were analyzed by LC and CE. The developed method has 97 
been applied to determination and quantification of enrofloxacin and its main metabolite 98 





2.1. Reagents 103 
Quinolones were purchased from various pharmaceutical firms: ciprofloxacin (CIP) (Ipsen 104 
Pharma, Barcelona, Spain), sarafloxacin (SAR), difloxacin (DIF) and tosufloxacin (TOS) (Abbot, 105 
Madrid, Spain), enrofloxacin (ENR) (Cenavisa, Reus, Spain), danofloxacin (DAN) (Pfizer, 106 
Karlsruhe, Germany), marbofloxacin (MAR) (Vetoquinol, Barcelona, Spain), piromidic acid 107 
(PIR), oxolinic acid (OXO), flumequine (FLU) and lomefloxacin (LOM) (Sigma, St. Louis, MO, 108 
USA), norfloxacin (NOR) (Liade, Boral Quimica, Barcelona, Spain), and pipemidic acid (PIP) 109 
(Prodesfarma, Barcelona, Spain). Structures of the studied quinolones are shown in figure 1. 110 
TOS, LOM, NOR and PIP were used as an internal standard in liquid chromatography and PIR 111 
was used as an internal standard in capillary electrophoresis. 112 
Plasma samples were purchased from Seguridad y Bienestar Animal S.L. (Bigues i Riells, Spain). 113 
All reagents were of analytical grade. Merck (Darmstadt, Germany) supplied phosphoric, acetic, 114 
formic, trifluoroacetic (TFA) and trichloracetic (TCA) acids, ammonium acetate, sodium 115 
hydroxide (NaOH), ammonia, hexane, acetonitrile (MeCN) and methanol (MeOH). Citric acid 116 
and potassium hydrogenphthalate were supplied by Fluka (Buchs, Switzeland). Ultrapure water 117 
generated by the Milli-Q system (Millipore, Billerica, MA, USA) was also used. 118 
119 
The SPE cartridges used in this study were as follows: ENV + Isolute (3 cm3 /200 mg; Isolute 120 
Sorbent Technologies, Hengoed, UK), Oasis HLB (3 cm
3
 /60 mg; Waters, USA) and Strata X (1 121 
cm
3 
/30 mg; Phenomonex, Torrance, USA). 122 
123 
The 0.45 µm pore size nylon filter membranes (Sharlab, Barcelona, Spain) were used to filter the 124 
extracts before the injection in the electrophoretic system.125 
126 
2.2. Instrumentation 127 
The LC-UV equipment by consisted of an HP 1100 series HPLC employing an injection valve 128 
with a 20 L sample loop. Detection was performed using a diode array detector (DAD) at 129 
maximum quinolone wavelengths (250 nm for FLU and OXO, 290 nm for LOM and MAR, and 130 
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280 nm for the rest of quinolones). A Chemstation for LC 3D Rev. A 08.03(847) software 131 
(Agilent Technologies) was used for data analysis. 132 
133 
The LC-MS and LC-MS/MS analysis were performed using an API 3000 triple-quadrupole mass 134 
spectrometer (PE Sciex) and data were collected with Analyst 1.4.2 software (Applied 135 
Biosystems, Foster City, CA, USA). 136 
137 
Chromatographic separation of the quinolones was performed on a Zorbax Eclipse XDB-C8 (150 138 
mm x 4.6 mm i.d.; Agilent Technologies, Waldbronn, Germany) column protected by a Kromasil 139 
C8 column (20 mm x 4.5 mm i.d.; Aplicaciones Analíticas, Barcelona, Spain).  140 
141 
A CE Beckman P/ACE system 5500 (Beckman Instruments, München, Germany) equipped with 142 
a photodiode array detector was used. The separation was performed as usual with the cathode at 143 
the detector end of the capillary. Detection was performed at the same wavelengths than in LC-144 
UV. P/ACE 5500 software of Beckman was used for data acquisition.  145 
146 
An uncoated fused-silica CE capillary column of 57 cm (50 cm from the inlet to the detector) and 147 
75 µm internal diameter (Polymicro Technologies, Phoenix, USA) was used. 148 
149 
A Crison 2002 potenciometer (±0.1 mV) (Crison, Barcelona, Spain) with an Orion 81025 C Ross 150 
combination pH electrode was used to measure the pH of the mobile phase. 151 
152 
A Mikro 20 mini-centrifuge from Hettich Zentrifugen (Hettich Zentrifugen, Germany) was used 153 
to centrifuge the final extract. SPE was carried out using a Supelco vacuum 12-cartridge manifold 154 
(Bellefonte, PA, USA) connected to a Supelco vacuum tank.  155 
156 
2.3. Standards and stock solutions 157 
Individual quinolone stock solutions of MAR, CIP, DAN, ENR, SAR, DIF and NOR at a 158 
concentration of 500 µg mL
−1
 were prepared in 50 mM acetic acid aqueous solution. Individual 159 




respectively, were prepared in MeCN. Individual quinolone stock solutions of TOS, LOM and 161 
PIP at a concentration of 100 µg mL
−1 
were prepared in 50 mM acetic acid: MeCN (80:20; v/v).  162 
163 
PIR (internal standard used in CE) was prepared in 50 mM acetic acid-MeCN (20:80; v/v) at a 164 
concentration of 100 µg mL
-1
. Working solutions, containing all quinolones except the internal 165 
standard, were prepared using stock solutions diluted with Milli-Q water at a concentration of 40, 166 
10, 5, 1, 0.5, 0.05 and 0.01 µg mL
−1
. These solutions were stored at 4 ºC. 167 
168 
Standard buffers of potassium hydrogenphtalate (0.05 mol kg
-1
), prepared in a hydroorganic 169 
mixture (9 and 14 % MeCN), with a pH of 4.25 and 4.38, respectively (Barbosa et al. 1999), 170 
were used to calibrate the pH-meter.171 
172 
2.4. Procedures 173 
174 
2.4.1. Sample treatment 175 
0.5 millilitres of cow or pig plasma was placed in a 1.5 mL polypropylene eppendorf tube. 176 
Appropriate volumes of working solutions and I.S. were added. When the final extracts were 177 
analyzed by LC, the concentration of I.S. was 1000 µg L
-1
. When the extracts were analyzed by 178 
CE, a concentration of 2500 µg L
-1 
of I.S. was used. After gently mixing of samples and in order 179 
to improve the retention of quinolones on the SPE cartridge, Milli-Q water was added to obtain a 180 
final volume of 1.5 mL.  181 
182 
2.4.2. Protein precipitation 183 
Prior to carrying out SPE extraction, different agents were tested for the protein precipitation. 1 184 
mL MeCN or 0.5 mL 10 % TCA was added to the plasma sample and mixed for 1 min using a 185 
vortex. The samples were then centrifuged at 12000 rpm for 5 min. Supernatant was transferred 186 
to a 15 mL polypropylene tube and 10 mL of Milli-Q water was added to decrease any high 187 
concentrations of MeCN or TCA.  188 
189 
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2.4.3. Solid-phase extraction  190 
Three different commercial cartridges based on a polymeric sorbent (Strata X, Oasis HLB and 191 
ENV+ Isolute) were examined in this study. Strata X are based on a poly(benzylpiperidone) 192 
polymer, Oasis HLB on a poly(divinylbenzene-co-N-vinylpyrrolidone) polymer, and ENV+ 193 
Isolute on a hyper cross-linked polystyrene-divinylbenzene polymer with a hydroxylated surface. 194 
In table 1, the optimized SPE conditions (activation, clean-up and elution) are shown. The 195 
solution obtained from the SPE was evaporated to dryness at 45 ºC under a stream of air and the 196 
residue was dissolved in corresponding mobile phase depending on the separation techniques 197 
used. 198 
199 
2.4.4. Separation 200 
201 
2.4.4.1 Chromatographic conditions  202 
For LC-UV, we used a gradient program featuring a mobile phase that combined solvent A (10 203 
mM citric acid: MeCN (91:9, v/v), adjusted with NH3 and solvent B (MeCN) as follows: from 0 204 
to 5 min the mobile phase contained 9% MeCN; from 5.0 to 11.5 min, the percentage of MeCN 205 
linearly increased to 12.5%; from 11.5 to 22.0 min, it increased to 27%; from 22.0 to 24.0 min, to 206 
39%, maintaining this  level until the 26.0 min mark. Finally the MeCN percentage decreased to 207 
9% from 26.0 to 29.0 min. The flow rate was 1.5 mL min
−1
, the injection volume was 20 µL. The 208 
separation of the quinolones was obtained in 26 min. The pH of the mobile phase were adjusted 209 
at 5 when samples of cow plasma and pH 4.5 when samples of pig plasma were analysed. 210 
211 
For LC-MS and LC-MS/MS, the citric acid from the mobile phase was replaced by ammonium 212 
acetate to obtain a more volatile mixture. The initial mobile phase used in LC–MS and LC–213 
MS/MS was MeCN:water (14:86,v/v) with 5 mM ammonium acetate and adjusted to a pH 2.5 214 
with formic acid. In this case, was not necessary to achieve complete separation if the ions 215 
monitorized are different. Because of this reason, the chromatographic gradient used was as 216 
follows: from 0 to 5.0 min, the MeCN percentage linearly increased to 21%; from 5.0 to 6.0 min, 217 
it increased to 24%; from 6.0 to 7.5 min, to 25%; and from 7.5 to 9.0 min, to 54% where it 218 
remained until 11.0 min. Finally the MeCN percentage decreased to 14% from 11.0 to 14.0 min. 219 
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The flow rate was 1.0 mL min
−1
. Under these conditions, the chromatographic separation of the 220 
10 quinolones was achieved in approximately 12 min.221 
222 
2.4.4.2. Electrophoretic conditions 223 
50 mM of H3PO4 adjusted at pH 8.4 with NaOH was used to prepare the electrophoretic 224 
solutions. All running buffer solutions, were prepared weekly and stored in a refrigerator before 225 
use and were filtered through a membrane filter (0.45 µm). 226 
When a new capillary was used, the capillary was activated for 30 min with 1 M NaOH solution, 227 
followed by 30 min with Milli-Q water. For preconditioning, the capillary was rinsed with 1 M 228 
NaOH and Milli-Q water for 15 min each, and then equilibrated with running buffer for 15 min 229 
applying a voltage of 15 kV. After each injection, the capillary was washed for 1 min with 1 M 230 
NaOH, 1 min with Milli-Q and 1 min running buffer to maintain proper reproducibility of run-to-231 
run injections. Sample injections were done in a hydrodynamic mode over 2 s under a pressure of 232 
0.5 psi at 25 ºC and separation voltage was 15 kV, in order to avoid high intensities.  233 
234 
2.4.5. ESI–MS and ESI–MS/MS parameters 235 
The MS conditions were optimized for the quinolones studied, directly injecting each compound 236 
individually at a flow-rate of 0.05 mL min−1 (Hermo et al. 2006). 237 
238 
When samples were analyzed, a post-column LC split (3:1) was used to reduce the flow-rate 239 
entering into the electrospray ionization source. A turbo ion-spray source in positive mode was 240 
used, since the amino group present in most quinolones is easily protonated in acidic media. 241 
Thus, we used the following settings: capillary voltage 4500 V; temperature 400 °C; nebulizing 242 
gas (NEB) (N2) 10 (arbitrary units); curtain gas (CUR) (N2) 12 (arbitrary units); collision gas 243 
(N2) 15 (arbitrary units); focusing potential (FP) 200 V; and entrance potential (EP) 10 V. In MS, 244 
Single-ion monitoring mode (SIM) experiments were performed using a dwell time of 200 ms to 245 
detect ions. Ions monitored by SIM mode and cone voltage for all compounds are displayed in 246 
table 2. 247 
248 
MS–MS product ions were produced by collision-activated dissociation (CAD) of selected 249 
precursor ions, in the collision cell of the triple quadrupole mass spectrometer. They were then 250 
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mass-analyzed using the second analyzer of the instrument. In all experiments, CAD gas 251 
(nitrogen) of 4 (arbitrary units) was used. Multiple reaction monitoring (MRM) mode was chosen 252 
for the experiments in MS-MS. The specific transition and collision energies used to quantify and 253 
confirm the quinolones in plasma samples are also shown in table 2. 254 
255 
2.5. Quality parameters 256 
Analyte stability for a given matrix is relevant only to that matrix and should not be extrapolated 257 
to other matrices. For this reason, it is regarded as a fundamental parameter for the validation of 258 
bioanalytical methods (Commission EU 2002; US Department 2001). Since the analysis is not 259 
performed immediately after sample collection, it is very important to know if drugs are stable at 260 
least during the storage time before the analysis. 261 
Quinolone stability in plasma was evaluated based on the freeze-thaw (F/T) cycles, storage 262 
stability in the refrigerator (holding time), and autosampler stability. F/T cycle consisted of the 263 
following: plasma samples containing each quinolone were stored at -20 ºC. Samples were 264 
removed from deepfreeze, equilibrated to room temperature and analyzed in duplicate. This 265 
process was repeated three times and the results were compared with control samples that had not 266 
undergone freezing. Storage stability in the refrigerator (holding time) of quinolones in plasma at 267 
4 ºC was evaluated in spiked samples. Samples were periodically removed from the refrigerator 268 
(at 0, 6, 12, 24, 48, 72, and 96 h), equilibrated to room temperature, and analyzed in duplicate. 269 
The results were then compared to determine refrigerator stability. Auto sampler stability of 270 
quinolones in the reconstituted plasma extracts was evaluated for 36 h in cow plasma and for 50 271 
h in pig plasma. 272 
273 
Quality parameters were established for the LC-UV, LC-MS and LC-MS/MS techniques for the 274 
developed method in cow and pig plasma, while CE-UV techniques were used for the analysis in 275 
pig plasma (Commission EU 2002; US Department 2001). To determine LOD and LOQ values, 276 
the plasma were spiked with working solutions at different concentration levels (between 5 and 277 
50 µg L
-1
 for LC-UV, between 100 and 500 µg L
-1
 for CE-UV, and between 0.1 and 25 µg L
-1
 for 278 
LC-MS and LC-MS/MS) in duplicate and subsequently injected in the separation system. The 279 
LOD and LOQ values were calculated by using a signal-to-noise ratio of 3 and 10, respectively. 280 
The LODs in LC-MS were obtained in single ion monitoring (SIM) mode using the most 281 
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abundant ion available. The LODs in LC-MS/MS were obtained with the transition of higher S/N 282 
reaction monitoring (MRM) mode. 283 
284 
In order to establish calibration curves by LC-UV, LC-MS and LC-MS/MS, between seven and 285 
twelve concentration levels of spiked cow and pig plasma, samples (LOQ-2500 g L−1) were 286 
prepared in duplicate and injected in the separation system. By CE-UV, eight concentration levels 287 
of spiked pig plasma samples were prepared in triplicate (LOQ-10000 µg L
-1
) due to dispersion 288 
dates. The results were presented with response of quinolone/ internal standard ratio vs. the 289 
quinolone/internal standard concentration ratio. Linear calibration curves were established using 290 
TOS as internal standards in LC and using PIR by CE. 291 
292 
In addition, the composition of these samples is rather complex with high protein and lipid 293 
contents, as well as other nutrients such as vitamins or mineral elements. Such a complex matrix 294 
requires extensive sample preparation procedures in order to quantitatively extract the antibiotics, 295 
avoiding matrix interferences. The observation of signal suppression (matrix effect) for some 296 
fluoroquinolones in ESI LC-MS and LC-MS/MS is a notable problem to discuss, due to the co-297 
eluting interferences. For evaluate the presence or absence of matrix effect, calibrations curves 298 
prepared in matrix and subjected to the sample treatment were compared with calibrations curves 299 
obtained when the plasma was substituted by water. 300 
301 
Recovery experiments were performed by comparing the analytical results of extracted standard 302 
samples (internal standards added prior to extraction) with those with plasma samples spiked 303 
after the extraction procedure, which exhibited 100% recovery in the concentration range where 304 
calibration curves were established. 305 
306 
To evaluate the intra-day-precision, five spiked plasma samples at three concentration levels each 307 
(50, 1000 and 2500 g L
−1
) were prepared and analysed by LC-UV. When LC-MS and LC-308 
MS/MS are the techniques used the high level were decreased until 2000 g L−1. When CE-UV is 309 
the technique used the levels of concentrations are 1000, 4000 and 8000 µg L
-1
. The procedure 310 
was repeated on three different days to determine the inter-day-precision.  311 
312 
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2.6. Positive pig and cow plasma samples. 313 
The method was applied to analyze treated pig plasma samples obtained from four pig specimens 314 
(A-D) orally medicated with 200 mg of ENR by kg of cattle feed, during five consecutive days. 315 
Plasma was stored at -20ºC until its analysis. The positive samples were analysed by LC-UV and 316 
CE-UV. ENR and CIP concentrations were quantified by a daily prepared calibration curve.  317 
Samples from pig intramuscular medicated with 2.5 mg kg
-1
 ENR were analysed after plasma 318 
samples were collected on 0h, 2h, 6h, 12h and 24h after treatment. Positive cow plasma samples 319 
were obtained from 3 cow specimens (A-C) orally medicated during 5 days with 1.5 g of ENR 320 
dissolving in drink water. The samples were collected while the animal was undergoing medical 321 
treatment.  322 
Plasma was obtained by centrifugation and stores at -20ºC until its analysis. The positive samples 323 
were analysed with the techniques more sensitive and selective, LC-MS and LC-MS/MS, in order 324 
to identify the antibiotics ENR and its main metabolite CIP. 325 
326 
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RESULTS AND DISCUSSION 327 
328 
3.1. Optimization of LC conditions 329 
In previous studies, analyses of quinolones from food samples by LC-UV were performed with 330 
10 mM citric acid with different percentages of MeCN at pH 4.5 by using a gradient elution 331 
timetable (Garcés et al. 2006; Hermo et al. 2006; Bailac et al. 2004). When the biological sample 332 
is cow or pig plasma, the pH of the mobile phase should to be changed to pH 5.0 in order to 333 
obtain better resolution between peaks of SAR and DIF. The maximum MeCN percentage value 334 
was set at 39%. Any increase above 40% resulted in a corresponding baseline increase (occurring 335 
between 25 and 27 min), which caused problems with FLU detection. Figure 2 shows the 336 
separation of quinolones in spiked cow plasma at a concentration of 1000 µg L
-1
 (for each 337 
quinolone), with the optimized analysis timetable. In blank samples, both LOM and TOS I.S. 338 
used are observed. Optimal separation of the eight quinolones and the two I.S. was achieved in 339 
less than 30 min. 340 
341 
As a more volatile mobile phase is needed for LC-MS and LC-MS/MS methods, citric acid from 342 
the mobile phase was replaced by ammonium acetate. In this case, as full separation of the 343 
quinolones was unnecessary, higher MeCN concentrations were used in order to reduce the 344 
analysis time. Under these new conditions, separation of eight quinolones from plasma as well as 345 
of the two internal standards used was achieved in 12 min, as can be observed in figure 3. Figure 346 
4 shows the resulting ion-reconstituted chromatogram when bovine spiked plasma was analyzed 347 







. In this table, we also show the quantification transition 349 
of the studied quinolones, including the I.S. The transition [M+H]+  [M+H-H2O]
+ was used for 350 





was used for MAR, and ENR. The identification transitions are also shown in table 2. As an 352 
illustrative example, the product ions from TOS and MAR, as well as our spectra interpretations, 353 




3.2. Optimization of CE separation 357 
Using CE methodologies Jiménez-Lozano et al. 2004), a simple and rapid method of separating 358 
and identifying the series of quinolones was developed. The optimization of the separation was 359 
carried out using pig plasma samples fortified at 10 mg L
-1
 of each quinolone. For this purpose, 360 
two different length of the capillary (Lt 47 and 57 cm) were tried, with different times of 361 
hydrodynamic injection (2, 4 and 6s). Best results were obtained with a capillary length of 57 cm 362 
and 2 s hydrodynamical injection at 50 psi. A 15 kV voltage with a normal polarity was applied. 363 
Under these conditions, the time need for the total separation of the compounds was 14 min. 364 
365 
3.3. Selection of the SPE cartridge 366 
Various hydrocarbon chain-, polymeric-, and mixed sorbent-based cartridges have been 367 
previously evaluated for quinolones determination in different matrices (Hermo et al. 2005; 368 
Jiménez-Lozano et al. 2004). In plasma, different types of sorbents were tested in this work 369 
(Strata X, Oasis HLB and ENV+ Isolute). To detect interfering substances from the matrix, blank 370 
bovine plasma was analyzed using these cartridges. Similar chromatograms were obtained with 371 
the three sorbents, although interfering substances were present to a lesser extent when Strata X 372 
were used. Good recoveries (higher than 90%) were obtained with the three sorbents. In table 1 373 
the optimized experimental conditions for each sorbent are shown. To obtain good recoveries 374 
with ENV+ Isolute and Oasis HLB, a greater elution solution volume than that provided by Strata 375 
X was needed. As a consequence, evaporation time and sample preparation time was higher with 376 
ENV+ Isolute and Oasis HLB. When the elution solution volume added to ENV+ Isolute and 377 
Oasis HLB was the solution used for Strata X (2 mL of 1% TFA:MeCN (25:75, v/v)), decrease 378 
evaporation times, but quinolone recoveries also decreased (≈ 70% and 80%, respectively). To 379 
decrease sample preparation time and organic solvent consumption, thereby ensuring high 380 
recoveries, Strata X was selected as the best cartridge for the analysis of plasma samples. 381 
382 
Although endogenous plasma interference was minimized with Strata X, the presence of 383 
interfering substances was not eliminated. To obtain cleaner baselines, we tried different washing 384 
steps in SPE and also introduced a protein precipitation step before SPE application. However, 385 
regardless of the additional washing solution used [1 mL 0.5 % TFA:MeCN (90:10), 2 mL 0.5 % 386 
TFA:MeOH (90:10), 2 mL 0.5 % TFA:MeOH (80:20) and 3 mL hexane], there were no 387 
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significant differences between chromatograms involving washing solely with water and those 388 
including additional steps. When we introduced protein precipitation steps involving MeCN or 10 389 
% TCA, cleaner baselines were obtained, although quinolones recoveries were 70% for MAR and 390 
CIP and 50% for the others. In both cases, a part of quinolones elute in the organic solvent and 391 
the acid fraction, respectively and thus, to obtain high recoveries with maximum simplicity, the 392 
protein precipitation step was not considered, and 2 x 1 mL Milli-Q water was selected as the 393 
ideal wash solvent. Indeed, it removed the majority of impurities without affecting quinolone 394 
retention and recovery. 395 
396 
Eluates were evaporated to dryness at 45 ºC under a stream of air and residue was redissolved in 397 
200 µL of mobile phase when the LC was used and 100 µL of MeCN:Milli-Q water (50:50;v/v)  398 
was added for analysis by CE.  399 
400 
3.4. Selection of the internal standard 401 
For the selection of the I.S. in this work, two requirements were considered: firstly, the time 402 
retention of the I.S. was proper to every quinolones studied and, the second requirements consist 403 
to minimize the interfering substances from the plasma matrix with the standard internal. Under 404 
these premise, four different quinolones were tested as potential I.S. for LC-UV quantification: 405 
NOR, PIP, LOM and TOS. NOR has not been used as an I.S. in cow plasma due to an interfering 406 
substance that appears at the same retention time than NOR. PIP was the first substance to be 407 
separated from the mixture at the 5.7 min mark, far below that of the next substance, whose 408 
retention time was 10 min. On the other hand, LOM and TOS present adequate retention times 409 
and minimum interferences. At 13.4 min, LOM fell between CIP and DAN, while at 20 min, 410 
TOS fell between DIF and OXO. Therefore, we used both substances LOM and TOS as I.S. 411 
412 
Table 3 shows as an example, the slope, intercept and recovery of quinolones for both I.S. in cow 413 
plasma, when LC-UV is used. A two-factor ANOVA test was applied to evaluate the recoveries 414 
values, obtained from the two I.S. selected (LOM and TOS) for all quinolones. The ANOVA test 415 
revealed differences in recoveries when both internal standards were used. As can be seen in 416 
table 3, the calibration curves are also different using both I.S. Ratio of 1,8 between slopes are 417 
obtained. As a similar working concentration of I.S. had been used, we attributed this variance to 418 
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the different absorbance levels of LOM and TOS in UV. These differences between I.S. reflect 419 
the high response of LOM, which decreased the area of quinolone/area I.S. ratio. Consequently, 420 
there was a decrease in the slope value of the calibration curve. When LOM and TOS were 421 
analyzed by LC-MS also a different signal is obtained as can be seen in figure 6A, where ions 422 
monitored by LC-MS for LOM and TOS are shown at the same concentration of 1000 g L−1. 423 
Figure 6B shows the different intensity of the quantification transitions for LOM and TOS when 424 
quinolones were analyzed by LC-MS/MS. The slope values revealed that significantly greater 425 
sensitivity was obtained in these techniques when TOS served as the I.S. Thus, we recommend 426 
TOS as the I.S. when cow or pig plasma were analyzed by LC. 427 
428 
Using CE-UV, different quinolones were tested as potential internal standards for quantification. 429 
TOS and PIR present the best characteristics, but TOS migrates between CIP and MAR, making 430 
difficult the quantification of CIP and MAR, so PIR was selected as I.S. in the CE analysis. 431 
432 
3.5. Quality parameters  433 
The quinolones assay was validated with respect to stability, LOD and LOQ, linearity, precision, 434 
accuracy and selectivity (Commission EU 2002; US Department 2001).  435 
436 
Antibiotic stability was evaluated in cow and pig plasma and analyzing by LC-UV. Quinolone 437 
stability (at 1000 g L−1 per compound) was evaluated based on the F/T cycles, storage stability 438 
in refrigerator (holding time) and autosampler stability. These experiments were performed as 439 
described in Section 2.5. Similar results were obtained for F/T cycles. Recoveries obtained in this 440 
study were similar to those obtained from control samples without freezing. In relation to the 441 
storage stability in the refrigerator, only some differences are obtained for CIP and SAR 442 
depending on the kind of plasma (pig or cow). Figure 7, shows the recovery vs. time that plasma 443 
samples stayed in the refrigerator at 4ºC. Both CIP and SAR in cow plasma present similar 444 
recoveries over the period of time studied. When pig plasma is considered CIP and SAR are 445 
stable at least for 24-48 h, and after this time recovery clearly decrease. The autosampler stability 446 
of the extracts was also studied for 36 h with extracts from cow plasma and for a long period of 447 
time with extracts from pig plasma. Similar results were obtained to those obtained from control 448 
samples. A one-factor ANOVA test was applied to evaluate the concentration of each quinolone 449 
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in the three stability studies. The results obtained showed no statistically significant differences 450 
between measurements (pcalculated > 0.05) and because of this, we concluded that the quinolones 451 
were stable throughout 3 F/T cycles and in mobile phase solution for 36 h stayed in the 452 
autosampler. All quinolones were also stable at least for 96h in the refrigerator except for CIP 453 
and SAR in pig plasma, whose concentration decreases from 24 to 48 h. 454 
455 
The LOD and LOQ of quinolones in cow and pig plasma by LC and CE were estimated based on 456 
the results of two plasma replicates spiked at different levels of concentration. LOD and LOQ 457 
values are shown in table 4. Lowest LOD and LOQ values were obtained when MS-MS was used 458 
as the detection technique. The LOD and LOQ values obtained from LC-MS were from 5 to 20 459 
times below those determined by LC–UV, while for LC-MS/MS, the LOD were at least 50 times 460 
less than those of LC–UV. CE-UV had offer lower sensitivity in terms of LOD and LOQ that are 461 
between 7 and 15 times higher than the obtained values using LC-UV. 462 
463 
The calibration curves established for all compounds yielded high correlation coefficients, all of 464 
them higher 0.91, as can be seen in table 4. The calibration curve generated for the some of the 465 
quinolones by LC-MS and LC-MS/MS revealed a loss of linearity at high levels of concentration 466 
(above 2000 g L
−1
). In evaluating the slope of calibration curves, similar values in the slope of 467 
the curves from pig and cow plasma in LC-UV (except for OXO) were obtained and in 468 
conclusion a similar behavior of quinolones in the two matrixes is observed. 469 
470 
One significant drawback of electrospray mass spectrometry is that the ionization source is highly 471 
susceptible to co-extracted matrix component. It may also produce erratic quantitative results in 472 
LC-ESI-MS analysis due to the “matrix effect”. Because of this, the variation instrument 473 
response (matrix effects) on the signal intensities of target antibiotics in LC-ESI-MS was 474 
investigated. For evaluate this effect, it was prepared calibration curves where the plasma was 475 
substituted by water. The slope of this calibration curves where compared with the slope of the 476 
calibration curves prepared in plasma. Table 5 shows the results of the curves prepared in water 477 
and registered by ESI-MS and ESI-MS/MS. Comparing these data with those obtained in plasma 478 
(table 4) and applying a two vies ANOVA test, we concluded that the calibration curves (in 479 
matrix) and standard curve (in water) registered in MS and MS/MS are different and a matrix 480 
18
effect was found for most antibiotics in cow and pig plasma. An ANOVA test made to compare 481 
cow and pig plasmas show no difference between these plasmas, and in conclusion these samples 482 
present similar matrix effect. 483 
484 
Recoveries of quinolones from plasma samples are shown in table 6. In all analysis techniques, 485 
recovery values were higher than 80 %. Moreover, in all cases, comparable results were obtained 486 
regardless of the method employed, as has been discussed above. 487 
488 
The intra- and inter-day precision was evaluated at three concentration levels as has been 489 
explained in section 2.5. Based on FDA for bioanalytical validation (US Department 2001), the 490 
%RSD values from repeated analyses of spiked samples should not exceed 15%. The RSD% 491 
values of intra- and inter-day are also shown in table 6. The RSD percentage values of the 492 
methods are below 15% excepted for FLU by CE with a value of 16%; which indicates that, in 493 
general, they boast suitable intra- and inter-day precision. 494 
495 
3.6. Application of the developed methods to positive plasma samples obtained from medicated 496 
animals 497 
In order to test the efficiency of the proposed methods and compare CE-UV and LC-UV, we have 498 
applied the developed methods to the determination of ENR and its main metabolite CIP in pig 499 
plasma samples from four animals orally medicated with ENR during five consecutive days. 500 
501 
Figure 8 shows the differences between plasma concentration-time profiles obtained by LC-UV 502 
versus CE-UV in the analysis of ENR in four pig plasma of treated animals (A-D). The 503 
concentration obtained of ENR in pig plasma is around 1000 µg L
-1
 using both techniques. 504 
505 
Figure 9A shows: (a) a blank pig plasma sample and (b) an electropherogram of a pig plasma 506 
sample spiked at a concentration of 1000 µg L
-1
 of each quinolone. Figures 9B and 9C show the 507 
UV peaks corresponding to the analysis of ENR and I.S. in a positive plasma sample obtained 508 
from a treated animal with ENR. In figure 9B, obtained by CE-UV, the peak corresponding to 509 
CIP doesn’t appear because its concentration, in the real sample, is lower than the LOD obtained 510 
with this technique. However, using LC-UV (figure 9C), the obtained chromatogram permits to 511 
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know the presence of ENR but also of its metabolite CIP, whereas at a concentration lower than 512 
the LOQ. 513 
514 
In order to test the efficiency of the proposed methods and also quantify and identify the positive 515 
quinolones samples, LC-MS and LC-MS/MS has been used for the determination of ENR and its 516 
main metabolite CIP in pig and cow plasma samples obtained from animals medicated with ENR. 517 
518 
Figure 10 shows the pharmacokinetic profile for the ENR and CIP contents, in the analysis of 519 
plasma samples at five different times (0 h to 24 h), from pig plasma of treated animals using LC-520 
MS and LC-MS/MS. Between 2 and 6 h, the highest value of ENR in plasma samples is 521 
observed. After 6 h the concentration of ENR decrease and a part of ENR is metabolized to CIP, 522 
as can be observed in figure 10. Similar concentration values are obtained by LC-MS and LC-523 
MS/MS. 524 
525 
Figure 11 shows, as an example, the results obtained in the analysis by LC-MS/MS of a positive 526 
pig plasma sample from an animal treated with ENR. This figure shows: (11a) a chromatogram 527 
obtained before the treatment (0 h) and (11b) after 6 h. The use of LC-MS/MS allows the 528 
quantification of ENR and CIP using the corresponding transition in MRM mode and also the 529 
univocal confirmation of the presence of ENR and CIP by the transition of identification, as can 530 
be shown in figure 11c. 531 
532 
In this work we have also studied the application of MS methodologies to the analysis of 533 
quinolones in positive cow plasma samples, from three cow specimens (A, B and C) medicated 534 
with ENR. Comparable results are obtained by LC-MS and LC-MS/MS for ENR and CIP. The 535 
values in parenthesis are the standard deviation obtained. The different results obtained for A, B 536 
and C specimens can be explained taking into account that the concentration found depends on 537 
the volume of water that each animal has drunk. 538 
539 
The results show that CE-UV is satisfactorily applied when relatively high values of 540 
concentration of quinolones are present, but techniques as LC-MS or LC-MS/MS are needed in 541 
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order to quantify low levels of analytes and also to quantify the metabolite CIP in plasma samples 542 
after the treatment with ENR. 543 
544 
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4. CONCLUSIONS 545 
546 
LC-UV, LC-MS, LC–MS/MS and CE-UV methods were developed and applied in order to 547 
identify and quantify simultaneously a series of quinolones in cow and pig plasma samples. A 548 
rapid and efficient SPE method was optimized for extraction and clean-up of quinolones from 549 
plasma. CE-UV, LC-MS and LC-MS/MS allowed us to greatly reduce the separation run-time, 550 
compared with LC-UV. 551 
552 
Detailed validation studies were performed to evaluate the effectiveness of these methods based 553 
on FDA regulations, obtaining adequate sensitivity, linearity and precision results. The precision 554 
of each method was below the 15% required by EU regulation excepted for DIF and FLU in CE 555 
with a value of 16 %. The recoveries of the quinolones were higher than 80% in all methods. The 556 
lowest LOQ were obtained with LC-MS and LC-MS/MS. Similar parameters are obtained with 557 
both pig and cow plasma in LC-UV.  558 
559 
The studies made show a matrix effect cow and pig in plasma, showing different slopes between 560 
calibration curves prepared in plasma and prepared in water. In conclusion to analyze positive 561 
samples the calibration curves showed to be prepared in the corresponding plasma. 562 
563 
Despite the low sensitivity of the CE-UV, this technique has been satisfactorily applied to 564 
identify and quantify ENR in plasma samples from animals orally medicated, obtaining similar 565 
results than using LC-UV. However, techniques as the LC-MS or LC-MS/MS are needed when 566 
low concentration of ENR and CIP are present in the samples. 567 
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Figure 1. Chemical structure of the studied quinolones and the I.S. used. 655 
656 
Figure 2. LC-UV chromatograms of spiked cow plasma samples at 1000 µg L
-1
 of quinolone (a, 657 
b, and c) and blank plasma (d, e, and f). IS (LOM and TOS) at 1000 µg L
-1
. Extracts were 658 
analyzed at 280 nm (a and d), 250 nm (b and e) and 300 nm (c and f).  659 
Peaks: (1) MAR; (2) CIP; (3) LOM (IS); (4) DAN; (5) ENR; (6) SAR; (7) DIF; (8) TOS (IS); (9) 660 
OXO; and (10) FLU. 661 
662 
Figure 3. LC-MS chromatogram obtained from the analysis of spiked cow plasma samples at 100 663 
µg L
-1
 per quinolone in SIM mode. Peaks as in figure 2.  664 
665 
Figure 4. Ion reconstituted chromatogram obtained for the analysis of spiked cow plasma samples 666 
at 50 µg L
-1
 per quinolone by LC–MS/MS in MRM mode.  667 
668 
Figure 5. Mass spectrum in product-ion scan mode for A) Tosufloxacin: m/z 405 at collision-669 
induced dissociation in q2 at 32V and the proposed fragmentation pathways, B) Marbofloxacin: 670 
m/z 363 at collision-induced dissociation in q2 at 30V and the proposed fragmentation pathways. 671 
672 
Figure 6. A) Comparison between the responses of LOM and TOS by LC-MS at 1000 µg L
-1
. B) 673 




Figure 7. Comparison between storage stability at 4ºC in the refrigerator for CIP and SAR in cow 676 
and pig plasma. 677 
678 
Figure 8. Concentration (µg L
-1
) of ENR in pig plasma from four pigs medicated with ENR (time 679 
of extraction of 24 h), obtained by LC-UV and CE-UV. 680 
681 
Figure 9. A) Electropherograms  (260 nm) of blank pig plasma samples (a), pig plasma samples 682 
spiked at a concentration of 1000 g L
-1




(b). B) Electropherogram (260 nm) of a pig plasma sample from medicated animal with ENR by 684 
CE-UV. PIR at 2500 g L
-1
. C) Chromatogram (280 nm) of pig plasma sample, from medicated 685 
animal with ENR obtained by LC-UV. TOS at 1000 g L
-1
. Peaks: (1) DAN; (2) CIP: (3) MAR; 686 
(4) ENR; (5) DIF; (6) PIR (IS); (7) OXO; (8) FLU; (9) TOS (IS). 687 
688 
Figure 10. Concentration-time profile of (a) ENR and (b) CIP in plasma samples obtained from 689 
pig animals after medication with ENR and analyzing by LC-MS (SIM mode) and LC-MS/MS 690 
(MRM mode). 691 
692 
Figure 11. Ion reconstituted chromatogram obtained for the analysis of pig plasma sample 693 
corresponding to an animal treated with ENR (a) before the medical treatment, (b) 6 h after the 694 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3. Comparison of the results obtained by LC-UV in calibration curves and recovery for both IS 
(LOM and TOS) used, in cow plasma. 
 MAR CIP DAN ENR SAR DIF OXO FLU 
LC - UV
   IS (LOM) 
      Slope 0.936 1.091 1.162 1.293 0.983 0.954 1.033 0.862 
      Intercept 0.011  - 0.024  - 0.020  - 0.015  - 0.021 0.004  - 0.007  - 0.009 
      r 0.9998 0.9996 0.9999 0.9999 0.9996 0.9998 0.9995 0.9998 
       %Recovery 92 (± 1) 91 (± 1) 92 (± 1) 93 (± 1) 91 (± 1) 92 (± 1) 93 (± 1) 92(± 1) 
   IS (TOS) 
      Slope 1.732 2.018 2.148 2.391 1.818 1.764 1.915 1.594 
      Intercept 0.009  - 0.054  - 0.048  - 0.042  - 0.049  - 0.003  - 0.038  - 0.026 
      r 0.9998 0.9995 0.9999 0.9999 0.9996 0.9999 0.9995 0.9996 
        %Recovery 96 (± 1) 93 (± 1) 95(± 1) 97(± 1) 94 (± 1) 96 (± 1) 99 (± 2) 96 (± 1) 
y = Slope*C + Intercept (y=area quinolone/internal standard ratio; C = concentration quinolone/internal standard ratio). 
Table 4. LOD, LOQ and calibrations curves for quinolones in cow and pig plasma samples by 
different techniques. 
 MAR CIP DAN ENR SAR DIF OXO FLU 
COW PLASMA 
LC – UV 
a
        
      LOD (g L
−1
) 12 10 13 10 14 12 10 12 
      LOQ (g L
−1
) 40 35 45 35 47 41 35 41 
      Slope 1.732 2.018 2.148 2.391 1.818 1.764 2.643 1.594 
      Intercept 0.009  - 0.054  - 0.048  - 0.042  - 0.049  - 0.003  - 0.033  - 0.026 
      r 0.9998 0.9995 0.9999 0.9999 0.9996 0.9999 0.9995 0.9996 
LC – MS 
a
        
      LOD (g L
−1
) 1 2 0.5 0.5 1.5 1 0.5 0.5 
      LOQ (g L
−1
) 4 7 2 2 5 4 2 2 
      Slope 1.945 0.648 1.997 2.206 1.182 1.723 0.967 0.995 
      Intercept 0.172 0.134 0.273 0.417 0.147 0.280 0.211 0.194 
      r 0.985 0.920 0.984 0.980 0.978 0.985 0.963 0.974 
LC - MS/MS 
a
         
      LOD (g L
−1
) 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.1 
      LOQ (g L
−1
) 0.7 0.7 0.5 0.5 0.7 0.7 0.5 0.5 
      Slope 0.334 0.376 1.709 0.902 0.730 1.431 1.717 1.704 
      Intercept 0.027 0.040 0.087 0.041 0.001 0.079 0.238 0.230 
      r 0.984 0.960 0.997 0.998 0.997 0.997 0.965 0.984 
PIG PLASMA 
LC – UV 
a
         
      LOD (g L
−1
) 12 12 10 10 7 10 8 10 
      LOQ (g L
−1
) 40 40 31 31 23 40 25 40 
      Slope 1.633 2.150 2.124 2.356 1.679 1.620 1.209 1.504 
      Intercept -0.041 -0.037 -0.078 -0.097 -0.020 -0.018 -0.032 -0.033 
      r 0.999 0.999 0.999 0.999 0.998 0.999 0.998 0.999 
CE – UV 
b
         
      LOD (g L
−1
) 150 150 150 100 - 100 100 150 
      LOQ (g L
−1
) 450 450 450 300 - 300 300 450 
      Slope 0.930 0.589 0.636 0.670 - 0.564 1.314 1.107 
      Intercept -0.044 0.023 -0.023 -0.024 - -0.035 -0.058 -0.068 
      r 0.989 0.984 0.989 0.997 - 0.989 0.993 0.995
LC – MS
a
          
      LOD (g L
−1
) 1 2 1 1 2 1 1 1 
      LOQ (g L
−1
) 2.5 5 2.5 2.5 5 2.5 2.5 2.5 
      Slope 1.036 0.674 1.669 1.804 1.003 1.452 0.789 0.906 
      Intercept 0.385 0.112 0.342 0.593 0.234 0.364 0.248 0.261 
      r 0.940 0.910 0.974 0.950 0.970 0.970 0.950 0.960 
LC - MS/MS
a         
      LOD (g L
−1
) 0.3 0.4 0.1 0.2 0.3 0.3 0.1 0.1 
      LOQ (g L
−1
) 1 1 0.5 0.5 1 1 < 0.5 < 0.5 
      Slope 0.250 0.313 1.649 0.868 0.637 1.357 1.764 1.707 
      Intercept 0.040 0.037 0.029 0.017 0.035 0.065 0.099 0.130 
      r 0.970 0.950 0.998 0.998 0.996 0.997 0.990 0.992 
a 
The range of calibration curve was LOQ – 3200 g L
−1
 for LC-UV, LOQ-2000 for LC-MS and LC-MS/MS;  IS (TOS) 




 The range of calibration curve was LOQ – 10000 g L
−1
; IS (PIR) at a concentration of 2500 µg L
-1
. 
Calibration curve: y = Slope*C + Intercept (y=area quinolone/internal standard ratio; C = concentration 
quinolone/internal standard ratio).
Table 5. Calibration curves for quinolones in water samples by LC-MS and LC-MS/MS. 
Compound 
SIM  MRM 
Standard curve (in water) Standard curve (in water)
MAR y = 0,434C + 0,207 (r = 0,975) y = 0,085C + 0,002 (r = 0,988) 
CIP y = 0,298C + 0,144 (r = 0,991) y = 0,158C + 0,014 (r = 0,996) 
DAN y = 0,572C + 0,266 (r = 0,986) y = 0,422C + 0,036 (r = 0,995) 
ENR y = 0,922C + 0,160 (r = 0,980) y = 0,214C + 0,029 (r = 0,991) 
SAR y = 0,369C + 0,164 (r = 0,990) y = 0,178C + 0,011 (r = 0,997) 
DIF y = 0,574C + 0,215 (r = 0,990) y = 0,328C + 0,035 (r = 0,997) 
OXO y = 0,739C - 0,236 (r = 0,910) y = 0,345C + 0,180 (r = 0,930) 
FLU y = 0,422C + 0,119  (r = 0,991) y = 0,539C + 0,058 (r = 0,988) 
y = area quinolone/internal standard radio; C = concentration of quinolone/internal standard radio. 
Table 6. Data of recovery and precision of quinolones in cow and pig plasma by different techniques. 
MAR CIP DAN ENR SAR DIF OXO FLU 
BOBINE PLASMA 
LC - UV         

















        Precision (%)         
           Intra-day (n=15)
b
1 - 6 2 - 7 2 - 4 2 - 6 2 - 5 2  - 4 3 - 5 2 - 5 
           Inter-day (n=45)
b
2 - 7 3 - 8 3 - 6 3 - 8 3 - 5 2 - 9 2 - 6 3 - 9 
LC - MS         

















        Precision (%)         
           Intra-day (n=15)
b
3 - 7 3 - 6 4 - 7 2  - 7 2 - 4 1 - 3 4 - 9 2 - 8 
           Inter-day (n=45)
b
8  - 12 4 - 8 5 - 9 4 - 9 3 - 6 3 - 5 7 - 10 4 - 10
LC - MS/MS         

















        Precision (%)         
           Intra-day (n=15)
b
2 - 7 3 - 6 4 - 9 5 - 8 3 - 6 2 - 4 4 - 10 3 - 5 
           Inter-day (n=45)
b
5 - 10 3 - 6 5 - 11 6 - 10 4 - 7 4 - 5 6 - 11 4 - 8
PORCINE PLASMA 
LC - UV         

















        Precision (%)         
           Intra-day (n=15)
b
1 - 2 1 - 8 1 - 4 1 - 4 1 - 6 1 - 3 2 - 5 1 - 5 
           Inter-day (n=45)
b
1 - 3 1 - 8 1 - 5 2 - 5 1 - 7 1 - 4 3 - 9 2 - 7 
CE – UV         















        Precision (%)         
           Intra-day (n=15)
b
5 - 13 6 - 11 5 - 13 6 - 12 - 3 - 13 2 - 8 4 - 13 
           Inter-day (n=45)
b
12 - 13 10 - 13 10 - 14 12 - 14 - 12 - 16 9 - 14 8 - 16 
LC - MS         








 (± 6) 
94 







        Precision (%)         
           Intra-day (n=15)
b
5 - 13 1 - 13 2 - 7 5 - 7 2 - 14 6 - 8 6 - 8 8 - 14
           Inter-day (n=45)
b
9 - 12 9 - 13 4 - 11 7 - 15 4 - 14 5 - 10 8 - 14 11 - 12 
LC – MS/MS         








 (± 2) 
82 







        Precision (%)         
           Intra-day (n=15)
b
5 - 9 4 - 8 5 - 9 6 - 14 2 - 10 8 - 14 7 - 13 6 - 11 
           Inter-day (n=45)
b
10 - 13 8 - 15 5 - 12 7 - 15 5 - 14 9 - 15 8 - 14 10 - 15 
a 
Numbers in brackets are standard error (%). 
b
The intra- and inter-day data showed are the minimum and maximum RSD values obtained in the corresponding 
samples, which were prepared at 50, 1000 and 2500 µg L
−1 
for LC-UV; 1000, 4000 and 8000 g L
−1
 for CE-UV and 50, 
1000 and 2000 g L
−1
 for LC-MS and LC-MS/MS. 
Table 7. Results (µg L
-1
) obtained after the analysis of positive cow plasma samples. 
Enrofloxacin A B C 
LC-MS 156 (6) 153 (12) 130 (3) 
LC-MS/MS 142 (4) 139 (5) 116 (7) 
Ciprofloxacin    
LC-MS 93 (9) 111 (8) 99 (3) 
LC-MS/MS 86 (6) 95 (10) 83 (5) 
